<DOC>
	<DOCNO>NCT01256801</DOCNO>
	<brief_summary>The investigator want develop gene expression profile prediction immunotherapy response patient metastatic breast cancer present malignant pleural effusion .</brief_summary>
	<brief_title>Gene Expression Profiling Breast Cancer Cells Predict Response Malignant Pleural Effusion</brief_title>
	<detailed_description>1 . The patiets malignant pleural effusion randomizned treated cytokins ( inteleukin 2 ) dendritic cell ( DC ) plus cytokine induce killer cell ( CIK ) locally . 2 . Malignant pleural effusion metastatic breast cancer patient obtain thoracentesis centrifugalized enrich cancer cell therapy . 3 . The enriched cancer cell flash frozen store -80℃ processing . 4 . The gene expression pleural effusion detect microarray screen gene marker differently express group . 5 . Statistical analysis perform use unsupervised hierarchical cluster .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Pleural Effusion</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Pleural Effusion , Malignant</mesh_term>
	<mesh_term>Interleukin-2</mesh_term>
	<criteria>Patients histologically confirm metastatic breast cancer malignant pleural effusion Eastern Cooperative Oncology Group ( ECOG ) performance status 02 ; At least one measurable lesion ; Normal cardiac , hepatic , renal bone marrow function ; Life expectancy ≥3 month ; Discontinuity previous chemotherapy minimum 4 week . Not receive chemotherapy pleural cavity previous history malignancy ; previous surgery history needle biopsy organ ; Serious uncontrolled concurrent medical illness .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Metastatic Breast Neoplasms</keyword>
	<keyword>Gene Expression Profiling</keyword>
	<keyword>immunotherapy</keyword>
</DOC>